HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 614 filers reported holding HORIZON THERAPEUTICS PUB L in Q1 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $170,758 | +45.9% | 1,476 | +29.7% | 0.00% | 0.0% |
| Q2 2023 | $117,043 | +43.2% | 1,138 | +51.9% | 0.00% | – |
| Q1 2023 | $81,746 | -41.3% | 749 | -38.8% | 0.00% | -100.0% |
| Q4 2022 | $139,291 | +63.9% | 1,224 | -10.6% | 0.00% | – |
| Q3 2022 | $85,000 | -98.7% | 1,369 | -98.3% | 0.00% | -100.0% |
| Q2 2022 | $6,401,000 | -26.9% | 80,252 | -3.6% | 0.03% | -13.9% |
| Q1 2022 | $8,759,000 | -2.4% | 83,249 | -0.1% | 0.04% | +2.9% |
| Q4 2021 | $8,978,000 | -2.5% | 83,317 | -0.9% | 0.04% | -12.5% |
| Q3 2021 | $9,212,000 | +10.5% | 84,101 | -5.6% | 0.04% | +8.1% |
| Q2 2021 | $8,338,000 | +3.9% | 89,047 | +2.1% | 0.04% | 0.0% |
| Q1 2021 | $8,028,000 | +9690.2% | 87,228 | +7709.1% | 0.04% | – |
| Q4 2020 | $82,000 | -71.6% | 1,117 | -70.0% | 0.00% | -100.0% |
| Q3 2020 | $289,000 | -45.9% | 3,721 | -61.3% | 0.00% | -33.3% |
| Q2 2020 | $534,000 | +32.5% | 9,613 | -29.4% | 0.00% | 0.0% |
| Q1 2020 | $403,000 | -29.2% | 13,612 | -13.3% | 0.00% | 0.0% |
| Q4 2019 | $569,000 | +33.3% | 15,709 | +0.1% | 0.00% | 0.0% |
| Q3 2019 | $427,000 | -1.8% | 15,691 | -13.2% | 0.00% | 0.0% |
| Q2 2019 | $435,000 | – | 18,082 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |